Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
STA adds to drug service offerings
by Rick Mullin
April 3, 2017
| A version of this story appeared in
Volume 95, Issue 14
STA Pharmaceuticals, a division of the Chinese pharmaceutical services firm WuXi AppTec, is building its first commercial-scale finished drug facility. The company, which has manufactured clinical-scale finished drugs near Shanghai since 2007, will expand to commercial scale there and add production at its site in the city of Wuxi. The company recently added a pilot plant in Changzhou in a project aimed at integrating research and pharmaceutical chemical production. STA plans to double the number of process chemistry labs in Changzhou to 48, adding hydrogenation and catalysis labs, by the end of this year.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter